London, United Kingdom · Founded 2019 · Privately Held (backing)
Developer of a platform designed for pathogen analysis to create antigen and vaccine designs. Baseimmune is based in London, United Kingdom and was founded in 2019. It has raised $16.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$16.8M
Last round
—
Team — not yet on record
No current team members for Baseimmune are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Baseimmune with a free account
·The complete investor list: 15 names
·Watch Baseimmune: the Monday email on marks, rounds and moves